Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer

Journal of Clinical Oncology

Volumn 27, Issue 18, 2009, Pages 2946-2953

  Bilimoria, Karl Y ^a   Bentrem, David J ^a   Hansen, Nora M ^a   Bethke, Kevin P ^a   Rademaker, Alfred W ^a   Ko, Clifford Y ^a   Winchester, David P ^a   Winchester, David J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME; AGE; AXILLA; BREAST TUMOR; COMPARATIVE STUDY; LYMPH NODE; LYMPHADENECTOMY; MIDDLE AGED; MORTALITY; PATHOLOGY; TUMOR RECURRENCE;

AGE FACTORS; AGED; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

EID: 67649921350     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.5750     Document Type: Article

References (41)

1. Giuliano AE, Kirgan DM, Guenther JM, et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-398, 1994; discussion 398-401
2. Krag DN, Weaver DL, Alex JC, et al: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335-339, 1993; discussion 340
3. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Breast, version 2.2008. http://www.nccn.org/professionals/ physician-gls/PDF/breast.pdf
4. Lyman GH, Giuliano AE, Somerfield MR, et al: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703-7720, 2005
5. Natarajan S, Taneja C, Cady B: Evolution of lymphadenectomy in surgical oncology. Surg Oncol Clin N Am 14:447-459, v, 2005
6. Lucci A, McCall LM, Beitsch PD, et al: Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657-3663, 2007
7. Veronesi U, Paganelli G, Viale G, et al: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546-553, 2003
8. Chu KU, Turner RR, Hansen NM, et al: Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 229:536-541, 1999
9. Fant JS, Grant MD, Knox SM, et al: Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 10:126-130, 2003
10. Grube BJ, Giuliano AE: Observation of the breast cancer patient with a tumor-positive sentinel node: Implications of the ACOSOG Z0011 trial. Semin Surg Oncol 20:230-237, 2001
11. Guenther JM, Hansen NM, DiFronzo LA, et al: Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 138:52-56, 2003
12. Jeruss JS, Winchester DJ, Sener SF, et al: Axillary recurrence after sentinel node biopsy. Ann Surg Oncol 12:34-40, 2005
13. Naik AM, Fey J, Gemignani M, et al: The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: A follow-up study of 4008 procedures. Ann Surg 240:462-468, 2004; discussion 468-471
14. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140-1151, 2003
15. Hwang RF, Gonzalez-Angulo AM, Yi M, et al: Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 110:723-730, 2007
16. Katz A, Gage I, Evans S, et al: Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg 191:761-766, 2006
17. Fisher B, Jeong JH, Anderson S, et al: Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347:567-575, 2002
18. Kim T, Giuliano AE, Lyman GH: Lymphatic mapping and sentinel lymph node biopsy in earlystage breast carcinoma: A meta-analysis. Cancer 106:4-16, 2006
19. ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1 or T2 N0 M0 breast cancer who have a positive sentinel node. https://www.acosog.org/studies/synopses/Z0011-Synopsis.pdf
20. ACOSOGZ0011suspensionofregistration.https:// www.acosog.org/ announcements/announcement-display.jsp?id=c0875d5e-062a-4901- ba65-926a7637c451
21. Leitch AM, McCall L, Beitsch P, et al: Factors influencing accrual to ACOSOG Z0011, a randomized phase III trial of axillary dissection vs. observation for sentinel node positive breast cancer. J Clin Oncol 24:28s, 2006 (suppl; abstr 601)
22. Bilimoria KY, Stewart AK, Winchester DP, et al: The National Cancer Data Base: A powerful initiative to improve cancer care in the United States. Ann Surg Oncol 15:683-690, 2008
23. Standards for Cancer Registries: Data Standards and Data Dictionary (version 10.1; ed 8). Springfield, IL, North American Association of Central Cancer Registries, 2003
24. Facility Oncology Registry Data Standards. Chicago, IL, Commission on Cancer, 2004
25. Standards of the Commission on Cancer, volume II: Registry Operations and Data Standards. Chicago, IL, Commission on Cancer, 1998
26. Greene FL, Page DL, Fleming ID, et al (eds): AJCC Cancer Staging Manual (ed 6). Chicago, IL, Springer, 2002
27. Commission on Cancer: Approvals categories. http://www.facs.org/cancer/ coc/categories.html
28. Panageas KS, Schrag D, Riedel E, et al: The effect of clustering of outcomes on the association of procedure volume and surgical outcomes. Ann Intern Med 139:658-665, 2003
29. Ederer F, Axtell LM, Cutler SJ: The relative survival rate: A statistical methodology. Natl Cancer Inst Monogr 6:101-121, 1961
30. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-619, 1992
31. Park J, Fey JV, Naik AM, et al: A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg 245:462-468, 2007
32. Fisher B, Brown A, Mamounas E, et al: Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15:2483-2493, 1997
33. Fisher B, Anderson S, Bryant J, et al: Twentyyear follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002
34. Gadd M, Harris J, Taghian A, et al: Prospective study of axillary radiation without axillary dissection for breast cancer patients with a positive sentinel node. Presented at San Antonio Breast Cancer Symposium, San Antonio, TX, December 8-11, 2005
35. Katz A, Smith BL, Golshan M, et al: Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol 26:2093-2098, 2008
36. Peintinger F, Reitsamer R, Stranzl H, et al: Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 89:648-652, 2003
37. Purushotham AD, Upponi S, Klevesath MB, et al: Morbidity after sentinel lymph node biopsy in primary breast cancer: Results from a randomized controlled trial. J Clin Oncol 23:4312-4321, 2005
38. Truong PT, Vinh-Hung V, Cserni G, et al: The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. Eur J Cancer 44:1670-1677, 2008
39. Benson K, Hartz AJ: A comparison of observational studies and randomized, controlled trials. N Engl J Med 342:1878-1886, 2000
40. Concato J, Shah N, Horwitz RI: Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887-1892, 2000
41. Winchester DP, Trabanino L, Lopez MJ: The evolution of surgery for breast cancer. Surg Oncol Clin N Am 14:479-498, vi, 2005